The people in your care deserve nothing missed.
From the first worrying symptom to a result you can act on — guidance grounded in your region's standards, the right tests at accredited labs, and every abnormal value flagged before it slips through.
Close the laptop knowing every result was seen, every risk was raised, and every decision can be explained.
Why you can rely on it
What the platform does today
Your region's guidance
Advice follows NICE, MOHAP/DHA or USPSTF depending on where the practice operates.
Accredited laboratories
Orders route only to labs holding UKAS, ENAS or CAP/CLIA accreditation for the region.
Abnormal results flagged
Out-of-range values are flagged and explained, with one-click escalation.
A trail you can defend
Consent, access and clinical actions are recorded with who, what and when.
See it care for someone
No account · nothing stored
Describe a symptom and watch the triage ask the right questions, screen for red flags and suggest the blood tests worth doing.
Who is it for
Choose your role to see your workspace
Clinicians
From presenting complaint to confident result.
See how it worksPatients
Understand your health, order your own tests, stay in control.
See how it worksPractice administrators
Run the testing business, not the spreadsheet.
See how it worksHospital groups & networks
Every site, one governed platform.
See how it worksLaboratory partners
Receive requests. Return results. No fax.
See how it worksResearchers
From question to published manuscript, deterministically.
See how it worksHow it works
Patients
Something doesn't feel right, and you want answers without the waiting room.
You understand what's happening, and you decide who sees it.
- 01
Tell us what's troubling you
Describe symptoms in your own words. Triage screens for red flags first and gives emergency guidance for your country.
- 02
Order and book your sample
Choose suggested tests, fund them by self-pay, membership or insurance, and book a draw or home kit.
- 03
Read and share your results
Results arrive explained in plain English. Grant or withdraw practice access whenever you like.
Available modules in the platform
Every feature built today
Clinical triage & advisor
- • Guided history and red-flag screening
- • Suggested tests cited to regional guidance
- • Diagnosis and treatment explanations for clinician review
Light patient CRM
- • Searchable patient list with profile, photo and contact preferences
- • Multi-step intake: history, medicines, allergies, lifestyle, consent
- • Timeline of orders, results, reviews and escalations per patient
Documents & AI reading
- • Upload PDFs, photos or typed notes (stored privately)
- • AI transcription of results, diagnoses and medicines
- • Patient-reported data kept separate from AI-extracted data
Ordering & lab routing
- • Test catalogue, packages and basket
- • Print, email or laboratory-API dispatch
- • Routing by accreditation and buy price
Results & alerts
- • Abnormal and critical flags
- • Review, action and release to patient
- • Plain-English explanations
Medicines & escalation
- • Interaction, duplication and dosing checks
- • SBAR handover and referral letters
- • Urgency tiers with emergency guidance
Patient portal & consent
- • Track tests and view released results
- • Grant, narrow or revoke practice access
- • Clinic, home-visit, walk-in or kit collection
Laboratory console
- • Partner labs receive routed requests
- • Publish offered tests and prices
- • Return results into the clinician inbox
Billing & memberships
- • Self-pay, membership and insurance modes
- • Insurance claims and patient memberships
- • Card payments (currently in test mode)
Practice & governance
- • Team, roles and permission matrix
- • Single sign-on and multi-site networks
- • Clinical, access and system audit logs
Data connections
- • Laboratory order dispatch and result intake endpoints (per-lab setup)
- • Microsoft / Google SSO, email via your own Gmail, card payments
- • CSV bulk import; SNOMED CT, LOINC, CPT, HCPCS, ICD-10 codes on records
Monitoring & growth
- • Recurring monitoring-plan orders
- • Pricing calculator and business planner
- • Clinical and performance analytics
Research portal
- • AI-assisted chapter canvas
- • Citation curation and versioned publishing
- • Provenance kept on every snippet
Regions
- • UK, UAE and US settings
- • Currency, accreditation, coding and claim formats
- • Region-specific guidance and emergency numbers
Data connections are specific, configured integrations, not a general-purpose public API or app marketplace. Laboratory connections need per-lab setup; card payments run in test mode until live keys are connected.
Security, privacy & tenancy
Database-centred · multi-tenant · GDPR by design
Database-centred by design
Every test, price, patient, order, result, role and region rule lives as a structured database record. No hard-coded catalogues, every change traceable.
Multi-tenant companies
Each practice, clinic or laboratory is its own tenant. Records are stamped with the tenant and checked server-side on every read and write.
Group hierarchy
Link sites under a parent organisation (hospital group or network) with roll-up visibility across its sites.
Layered user permissions
Owner, admin, manager and viewer roles, plus custom roles with per-module permissions, SSO (Microsoft / Google) and bulk user provisioning.
Privacy by design (GDPR)
Built to support UK/EU GDPR: patient-controlled access grants, recorded and withdrawable consent, private file storage and account deletion.
Audit and provenance
Access changes, clinical actions and AI extractions are logged with who, what and when, so every decision can be explained.
Hosted on Base44 infrastructure, which holds SOC 2 attestation at platform level. Clinarivo itself is not independently SOC 2 certified, and GDPR support describes design controls; each practice remains the data controller responsible for its own compliance.
Built for three regulatory regimes
Resolved per practice from its region
United Kingdom
- UKAS ISO 15189
- NICE and the Royal Colleges
- SNOMED CT (UK Edition) with LOINC
- UK GDPR and the Data Protection Act 2018
United Arab Emirates
- ENAS ISO 15189
- MOHAP, DHA and DOH Abu Dhabi
- SNOMED CT with LOINC and ICD-10
- UAE Federal Personal Data Protection Law and DHA health data rules
United States
- CAP / CLIA certified
- USPSTF, AAFP and CDC
- CPT and ICD-10-CM with LOINC
- HIPAA and the HITECH Act
Published papers
Research published on the platform
- Version 2 · 23/10/2026
Indoor Air Quality and Human Physiology: A Sample Narrative Literature Review of Cognitive, Physical, Cardiorespiratory and Reproductive Outcomes
Background: populations in high-income settings spend approximately 90% of their time indoors, where exposure to carbon dioxide (CO2), fine particulate matter (PM2.5), nitrogen dioxide (NO2), volatile organic compounds (VOCs), dampness and mould, radon and combustion products is determined largely by ventilation, pollutant sources and building operation. Methods: this sample narrative review synthesised selected peer-reviewed literature across four domains, namely cognitive performance, physical performance, respiratory and cardiovascular health, and reproductive and embryo health. Sources were drawn from peer-reviewed journals and World Health Organization guidance known to the authors, prioritising meta-analyses, randomised and controlled-exposure studies and large cohorts; no protocol was registered and no systematic search was undertaken. Evidence was graded by strength throughout. Results: controlled-chamber and field studies associated lower ventilation and higher CO2 and VOC levels with reduced decision-making and work performance. Evidence on physical performance was mostly extrapolated from ambient and exercise-exposure studies, with limited indoor-specific data. Respiratory and cardiovascular effects were the best established: meta-analyses linked gas cooking and NO2, and dampness and mould, to asthma and wheeze, residential radon to lung cancer, and randomised air-purifier trials demonstrated short-term cardiopulmonary benefits. Reproductive evidence was emerging: household solid-fuel smoke was associated with low birth weight and stillbirth, and laboratory air quality appeared to influence in-vitro fertilisation outcomes, although human indoor fertility data remained sparse. Conclusions: indoor air quality is a modifiable determinant of human physiology, with the strongest evidence for respiratory and cardiovascular outcomes and comparatively weaker evidence for cognitive, physical and reproductive outcomes. Findings should be read as a narrative synthes
Read paper - Version 2 · 23/10/2026
Air Quality and Reproductive Health: A Global Narrative Evidence Review of Semen Quality, Ovarian Reserve, Premature Ovarian Insufficiency and Pregnancy Outcomes (Sample Draft)
Background: Across the human evidence reviewed, ambient and indoor air pollution emerged as a plausible, modifiable contributor to reproductive harm, with associations reported across semen parameters, ovarian reserve markers, menopause timing and pregnancy outcomes, yet the strength and consistency of this evidence, and whether it extends to diagnosed conditions such as premature ovarian insufficiency, has remained unclear. Methods: This narrative review synthesised global human epidemiological evidence, systematic reviews and meta-analyses, and authoritative public-health sources on exposure to PM2.5, PM10, NO2, SO2, ozone and black carbon in relation to semen quality, ovarian reserve, premature ovarian insufficiency and pregnancy outcomes, with mechanistic and animal evidence included only to support biological plausibility. Results: Meta-analytic evidence linked particulate matter, NO2 and SO2 exposure during spermatogenesis windows with lower total sperm number and motility. Systematic review evidence of moderate strength linked PM2.5 with lower anti-Müllerian hormone and antral follicle count, and a large cross-sectional study linked long-term PM2.5 and black carbon exposure with earlier natural menopause. Direct human evidence on premature ovarian insufficiency as a diagnosed outcome remained sparse, largely extrapolated from ovarian-reserve markers and animal data. Pregnancy evidence, covering preterm birth, low birth weight and stillbirth, was the most extensive and consistent evidence base, implicating both ambient and household PM2.5. Conclusions: The evidence is predominantly observational, affected by exposure misclassification and residual confounding, and should not be read as established causation. Nonetheless, the consistency of associations across semen parameters, ovarian reserve markers, menopause timing and pregnancy outcomes supports air pollution as a plausible, modifiable contributor to reproductive harm, warranting prospective cohort studies
Read paper